Cochrane Multiple Sclerosis and Rare Diseases of the Central Nervous System recently launched an international priority setting exercise. Here, the Co-ordinating Editors, Dr Graziella Filippini and Dr Francesco Nonino, tell us about their experience with priority setting and plans for evaluation and implementation. Why do you think it’s important to identify systematic review priorities?

International Survey on Research Priorities for Cochrane Systematic Reviews on Multiple Sclerosis In 2020, we started an international priority-setting project with the aim of identifying the most relevant topics in MS healthcare by evaluating research questions that should be addressed in future systematic reviews. Topics were identified and ranked through an anonymous, web-based questionnaire.

 Indagine internazionale sulle priorità per la ricerca nella sclerosi multiplaÈ on line una indagine internazionale per raccogliere le vostre opinioni e idee sui temi prioritari delle revisioni sistematiche Cochrane sulla sclerosi multipla.Invitiamo tutte le persone interessate, in particolare le persone con sclerosi multipla e i loro familiari, il personale sanitario e sociosanitario e i ricercatori a esprimere le loro idee su quali argomenti ritengono prioritari.Partecipa alla indagine !

Cochrane has released a Special Collection: Coronavirus (2019-nCoCV) to ensure immediate access to systematic reviews most directly relevant to the management of people hospitalized with severe acute respiratory infections. It includes reviews that are relevant to the WHO interim guidance, and reviews identified as relevant by Cochrane Acute and Emergency Care, informed by Cochrane groups in affected regions.

In collaboration with Centre for Health Communication and Participation Australian Institute for Primary Care & Ageing, Istituto di Ricerche Farmacologiche Mario Negri, Associazione Italiana Sclerosi Multipla (AISM), we have developed a project (IN-DEEP project), to facilitate knowledge translation for consumers.  The Australian and Italian teams have each created a web-site for people with MS and their family members that presents the evidence about a selection of MS treatments.

Published: 14 October 2018